Skip to main content
. 2019 Apr 11;24(6):e284–e291. doi: 10.1634/theoncologist.2018-0803

Figure 1.

image

Survival outcomes based on trial type. Median overall survival was comparable based on trial type: 12.8 years (95% CI, 11.9–13.7) and 13.5 years (95% CI, 12.9–14.1) in older‐patient‐specific trials and age‐unspecified trials, respectively. Similarly, median recurrence‐free survival was comparable based on trial type: 11.3 years (95% CI, 10.6–12.2) versus 12.7 years (95% CI, 11.9–13.6).

Abbreviation: CI, confidence interval.